Target intelligence / Profile preview

DENN domain containing 4A (DENND4A)

Target
DENND4A
Molecular classification
Guanine nucleotide exchange factor (GEF), DENN domain protein, DNA-binding protein
01

Overview

DENN domain containing 4A (DENND4A) is a protein expressed in humans with a DENN domain structure and functions as a guanine nucleotide exchange factor (GEF) for Rab10, a small GTPase involved in vesicle trafficking. DENND4A was originally identified as a protein binding to the interferon-stimulated response element in the MYC promoter and sometimes called C-myc promoter-binding protein. Its main characterized molecular role is in vesicle-mediated transport, activating Rab10 by promoting the exchange of GDP for GTP. Additionally, evidence suggests DENND4A may influence oncogenic processes by regulating MYC expression. Although linked to certain diseases such as cancer and inherited cardiomyopathy, its direct contribution to disease pathology remains under investigation. No drugs are currently approved to target DENND4A directly, and its role as a biomarker or its safety profile as a therapeutic target have not been established.

Other names
DENND4AC-myc promoter-binding proteinIRLBMYCPBPDENN domain-containing protein 4ADENN/MADD domain containing 4AMBP-1AI115600F730015K02RikRGD1562639
02

Biological functions

Guanyl-nucleotide exchange factor activity for Rab10 (activates Rab10 by promoting GDP→GTP exchange)DNA binding (binds interferon-stimulated response element in MYC promoter)Regulation of vesicle-mediated transport (Rab protein activation)Possible regulation of MYC oncogene expression
03

Disease associations

Cancer (MYC regulation links to oncogenesis)Cardiomyopathy, familial hypertrophic, 17 (OMIM association)Bullous retinoschisis (OMIM association)

Beyond the preview

Go deeper on DENN domain containing 4A (DENND4A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DENN domain containing 4A (DENND4A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call